{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:33:48Z","timestamp":1761896028432,"version":"3.37.3"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":1742,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006436","name":"Celgene Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1093\/annonc\/mdv010","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T05:30:37Z","timestamp":1421818237000},"page":"774-779","source":"Crossref","is-referenced-by-count":18,"title":["Utility of18fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma"],"prefix":"10.1016","volume":"26","author":[{"given":"S.","family":"Horwitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Coiffier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.M.","family":"Prince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Morschhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pinter-Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.P.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Shustov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Balser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Balser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdv010_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-3-5","article-title":"Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents","volume":"3","author":"Tan","year":"2010","journal-title":"J Hematol Oncol"},{"key":"10.1093\/annonc\/mdv010_bb0015","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1093\/annonc\/mdv010_bb0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nchembio.313","article-title":"Chemical phylogenetics of histone deacetylases","volume":"6","author":"Bradner","year":"2010","journal-title":"Nat Chem Biol"},{"year":"2014","series-title":"ISTODAX (romidepsin) [package insert]","key":"10.1093\/annonc\/mdv010_bb0025"},{"key":"10.1093\/annonc\/mdv010_bb0030","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1182\/blood-2010-10-312603","article-title":"Phase II trial of romidepsin in patients with peripheral T-cell lymphoma","volume":"117","author":"Piekarz","year":"2011","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv010_bb0035","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2011.37.4223","article-title":"Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy","volume":"30","author":"Coiffier","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv010_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-8722-7-11","article-title":"Romidepsin for the treatment of relapsed\/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses","volume":"7","author":"Coiffier","year":"2014","journal-title":"J Hematol Oncol"},{"key":"10.1093\/annonc\/mdv010_bb0045","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","article-title":"Peripheral T-cell lymphoma","volume":"117","author":"Foss","year":"2011","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv010_bb0050","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv010_bb0055","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/CCO.0b013e3282ce6f8f","article-title":"Management of peripheral T-cell non-Hodgkin's lymphoma","volume":"19","author":"Horwitz","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1093\/annonc\/mdv010_bb0060","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.clml.2013.07.005","article-title":"A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission","volume":"13","author":"Mehta","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1093\/annonc\/mdv010_bb0065","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","article-title":"Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors","volume":"31","author":"Mak","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv010_bb0070","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv010_bb0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.mayocp.2012.03.006","article-title":"Positron emission tomographic scans in lymphoma: convention and controversy","volume":"87","author":"Ansell","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1093\/annonc\/mdv010_bb0080","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1200\/JCO.2005.01.891","article-title":"Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography","volume":"23","author":"Juweid","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv010_bb0085","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv010_bb0090","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2967\/jnumed.108.053355","article-title":"Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer\/T-cell lymphomas of the head and neck","volume":"49","author":"Suh","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1093\/annonc\/mdv010_bb0095","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00277-008-0494-8","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies","volume":"87","author":"Khong","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1093\/annonc\/mdv010_bb0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3816\/CLM.2008.n.010","article-title":"The value of [(18)F]fluorodeoxyglucose positron emission tomography\/computed tomography in extranodal natural killer\/T-cell lymphoma","volume":"8","author":"Karantanis","year":"2008","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1093\/annonc\/mdv010_bb0105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/RLU.0b013e31816a7a23","article-title":"Disseminated extranodal NK\/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging","volume":"33","author":"Berk","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1093\/annonc\/mdv010_bb0110","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/annonc\/mdm265","article-title":"FDG-PET in T-cell and NK-cell neoplasms","volume":"18","author":"Kako","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdv010_bb0115","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1080\/10428190701344915","article-title":"F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas","volume":"48","author":"Bishu","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdv010_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MNM.0b013e32833310fa","article-title":"Utility of 18F-FDG PET\/CT for staging NK\/T-cell lymphomas","volume":"31","author":"Wu","year":"2010","journal-title":"Nucl Med Commun"},{"key":"10.1093\/annonc\/mdv010_bb0125","first-page":"1622","article-title":"18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease","volume":"47","author":"Hadithi","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1093\/annonc\/mdv010_bb0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2214\/AJR.09.3665","article-title":"Characterization of T-cell lymphomas by FDG PET\/CT","volume":"195","author":"Feeney","year":"2010","journal-title":"Am J Roentgenol"},{"key":"10.1093\/annonc\/mdv010_bb0135","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3109\/10428194.2013.767901","article-title":"FDG-PET in the staging and prognosis of T cell lymphoma","volume":"54","author":"Casulo","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdv010_bb0140","unstructured":"NCCN clinical practice guidelines in oncology: non-Hodgkin's lymphoma. V.5.2014 http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nhl.pdf (24 November 2014, date last accessed)."},{"key":"10.1093\/annonc\/mdv010_bb0145","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1200\/JCO.2010.29.9024","article-title":"Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study","volume":"29","author":"O'Connor","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv010_bb0150","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.2721.2721","article-title":"The role of interim-PET and final-PET in the outcome of peripheral T-cell lymphoma (PTCL) treated at the diagnosis with CHOP","volume":"120","author":"Pellegrini","year":"2012","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv010_bb0155","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.1809.1809","article-title":"Three-year survival results from an ongoing phase 2 study of brentuximab vedotin in patients with relapsed or refractory systemic anaplasitc large cell lymphoma","volume":"122","author":"Pro","year":"2013","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv010_bb0160","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/annonc\/mdq415","article-title":"18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T\/NK lymphomas: a study from the GOELAMS group","volume":"22","author":"Cahu","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdv010_bb0165","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3109\/10428194.2012.677535","article-title":"Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26\u201327 September 2011 and Menton 2011 consensus","volume":"53","author":"Meignan","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdv010_bb0170","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.4364.4364","article-title":"Interim positron emission tomography scan predicts early outcomes of patients with peripheral T-cell lymphoma","volume":"122","author":"Yhim","year":"2013","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv010_bb0175","article-title":"The prognostic significance of interim PET\/CT using visual, SUV-based and MTV-based assessment in treatment of peripheral T cell lymphoma","volume":"122","author":"Yang","year":"2013","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419314668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419314668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/4\/774\/16699483\/mdv010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:47:57Z","timestamp":1624520877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419314668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0923753419314668"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdv010","relation":{},"ISSN":["0923-7534"],"issn-type":[{"type":"print","value":"0923-7534"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}